These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31467228)

  • 1. Fusion of the Genes
    Panagopoulos I; Gorunova L; Lund-Iversen M; Bassarova A; Heim S
    Cancer Genomics Proteomics; 2019; 16(5):345-351. PubMed ID: 31467228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors.
    Suurmeijer AJH; Song W; Sung YS; Zhang L; Swanson D; Fletcher CDM; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2019 Sep; 58(9):643-649. PubMed ID: 30920708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PHF1-TFE3 fusion atypical ossifying fibromyxoid tumor with prominent collagenous rosettes: Case report with a brief review.
    Zou C; Ru GQ; Zhao M
    Exp Mol Pathol; 2021 Dec; 123():104686. PubMed ID: 34560087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Round cell tumor with a myxoid matrix harboring a PHF1-TFE3 fusion: Myoepithelial neoplasm or ossifying fibromyxoid tumor?
    Fei F; Prieto Granada CN; Harada S; Siegal GP; Wei S
    Pathol Res Pract; 2021 Sep; 225():153578. PubMed ID: 34391181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene of the month: TFE 3.
    Pinto K; Chetty R
    J Clin Pathol; 2020 Nov; 73(11):691-694. PubMed ID: 32820043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B-BCOR and PHF1-TFE3 fusions.
    Linos K; Kerr DA; Baker M; Wong S; Henderson E; Sumegi J; Bridge JA
    J Cutan Pathol; 2020 Oct; 47(10):934-945. PubMed ID: 32352579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of TFE3 Immunoexpression in a Spectrum of Cutaneous Mixed Tumors: A Retrospective Pilot Study.
    Zengin HB; Yildiz B; Pukhalskaya T; Smoller BR
    Dermatopathology (Basel); 2022 Jan; 9(1):48-53. PubMed ID: 35225876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Lobmaier I; Micci F; Heim S
    Cancer Genomics Proteomics; 2020; 17(3):237-248. PubMed ID: 32345665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
    Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
    Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHF1::TFE3-positive fibromyxoid sarcoma? Report of 2 cases and review of 13 cases of PHF1::TFE3-positive ossifying fibromyxoid tumor in the literature.
    Wei S; Patchefsky AS; Pei J; Brown SA; Basu Mallick A; Wang Z; Jiang W
    Am J Clin Pathol; 2024 Sep; ():. PubMed ID: 39250713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity!
    Patton A; Bridge JA; Liebner D; Chung C; Iwenofu OH
    Genes Chromosomes Cancer; 2022 Apr; 61(4):194-199. PubMed ID: 34874592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells.
    Hofvander J; Jo VY; Fletcher CDM; Puls F; Flucke U; Nilsson J; Magnusson L; Mertens F
    Mod Pathol; 2020 Jul; 33(7):1331-1340. PubMed ID: 31932680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
    Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
    Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene.
    Endo M; Kohashi K; Yamamoto H; Ishii T; Yoshida T; Matsunobu T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Nov; 44(11):2603-8. PubMed ID: 23806526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors.
    Gebre-Medhin S; Nord KH; Möller E; Mandahl N; Magnusson L; Nilsson J; Jo VY; Vult von Steyern F; Brosjö O; Larsson O; Domanski HA; Sciot R; Debiec-Rychter M; Fletcher CD; Mertens F
    Am J Pathol; 2012 Sep; 181(3):1069-77. PubMed ID: 22796436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma.
    Antonescu CR; Sung YS; Chen CL; Zhang L; Chen HW; Singer S; Agaram NP; Sboner A; Fletcher CD
    Genes Chromosomes Cancer; 2014 Feb; 53(2):183-93. PubMed ID: 24285434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion.
    Fukuda H; Kato I; Furuya M; Tanaka R; Takagi T; Kondo T; Nagashima Y
    Virchows Arch; 2019 Mar; 474(3):389-393. PubMed ID: 30552521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.